# Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.

> **NCT05716932** · — · COMPLETED · sponsor: **Dar El Oyoun Hospital** · enrollment: 14 (actual)

## Conditions studied

- Retinal Artery Macroaneurysm

## Interventions

- **PROCEDURE:** Dual focal laser and intravitreal Ranibizumab injection

## Key facts

- **NCT ID:** NCT05716932
- **Lead sponsor:** Dar El Oyoun Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-22
- **Primary completion:** 2023-01-21
- **Final completion:** 2023-01-21
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05716932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05716932, "Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05716932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*